Public technical beta · August 30, 2026

Use the tool.
Verify the science.

These evaluation terms set practical boundaries for the Molsim public technical beta. Features may change, and no workflow is production-class or validated as the sole basis for scientific decisions.

Technical-beta access

Molsim 0.1.0 is evaluation software. Features may change, and interruption or data loss is possible. Keep independent copies of important inputs and outputs. Download only from molsim.app and verify the checksum and release kind in the adjacent manifest.

Scientific use

Molsim helps prepare, execute, and analyze computational workflows. Results are models, not experimental facts. You are responsible for reviewing inputs, force fields, parameters, convergence, provenance, and conclusions.

Molsim is not a medical device and must not be used as the sole basis for clinical, safety-critical, regulatory, or treatment decisions.

Compute and third parties

Local compute is your responsibility. BYOC charges are between you and your infrastructure provider or institution. Every remote destination requires live validation before use. Molsim Cloud is not available in this beta. Third-party services such as model providers, Google identity, and Stripe apply their own terms.

Plans and billing

Community is free. Pro is USD 29 monthly or USD 290 annually. Lab early access is USD 149 monthly through contact-led evaluation; shared-seat administration is not yet self-service. Taxes may apply. Subscription changes and cancellations are handled through Stripe’s customer portal; cancellation ends renewal but does not retroactively erase valid charges.

Your responsibility

Use Molsim lawfully, protect credentials, respect software and dataset licenses, and do not attempt to bypass entitlement, security, cost, or isolation controls. Do not submit data to remote services unless you have authority to do so.

Contact

Questions: support@molsim.app. These terms cover evaluation of the public technical beta; commercial, regulated, or institution-wide deployment requires separate review and written terms.